Neuropathic pain: evidence matters (Q34558516)

3 August 2017

0 references

1 reference

title

Neuropathic pain: evidence matters (English)

1 reference

3 August 2017

0 references

Henry J McQuay

1

1 reference

3 August 2017

1 January 2002

1 reference

3 August 2017

European Journal of Pain

1 reference

3 August 2017

6 Suppl A

1 reference

3 August 2017

11-18

1 reference

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

3 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Desipramine relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0316

21 January 2018

Identifiers

DOI

10.1053/EUJP.2001.0316

1 reference

3 August 2017

1 reference

PubMed ID

11888235